Microsoft Business Solutions Axapta - Presentation Transcript
Microsoft Axapta For Life Sciences Mark Jensen General Manager Microsoft Business Solutions-Axapta
Agenda
Strategy
Business Drivers
Positioning and Value Proposition
Solution Overview
Partner Program and Certification
Readiness and Marketing
Microsoft Axapta Partner-Led Strategy Manufacturing Project Accounting Distribution Enterprise Portal HRM Financial Management Core CRM SCM Analytics Vertical Build & Partner Solution Development
Life Sciences Examples
Adverse Event Reporting
WMS (industry specific)
Corrective Action/Preventative Action (CAPA)
Laboratory Information Management (LIMS)
MBS Development ISV/Partner Development Apparel & Textile CPG Industrial Equipment Process Manufacturing Life Sciences Wholesale and Distribution Automotive Suppliers Construction High Tech and Electronics Metal Fabrication Professional Services Retail
Why a Life Sciences Platform?
Lower barriers to Life Sciences entry for our ISVs and partners
Complete the MBS overall strategy for the Life Sciences market
Microsoft Axapta Partners focused on Life Sciences
Significant market opportunity
Less competitive, more profitable vertical
Partner Feedback
ISV’s in this space support the platform approach
Components are not what the ISVs want to develop
Life Sciences Target Profile
Manufacturers
Distributors
FDA/ICH regulations
Primary ERP opportunity driver is Part 11 compliance requirements
More!
CXOs
VP Quality
Chief Compliance Officer
Common Thread (and Opportunity Driver!) Business Decision Makers
Pharmaceuticals – generic, brand name, and over-the counter
Medical Devices
Biotech
Nutriceuticals
Products Organizations
New drug development
Increase in counterfeiting
Mergers and acquisitions
Rising health care costs
FDA, ICH and other regulations
High Spend: Life Sciences 11.5% CAGR vs 7% average
Pharmaceuticals spend 5% of revenues on IT vs 3% average for all Manufacturing Source: IDC, 2002
Opportunity Drivers Life Sciences Business Drivers
What is Microsoft Axapta for Life Sciences?
Increased control over processes
Electronic signatures
Validation documentation
Partner Driven Components
Compliant implementation services
Core enhancement to address unique needs
Extend solutions such as LIMS, WMS…
Three Key Components
Product Positioning Industry: Life Science SIC / NACE code: 283-2835 Pharmaceuticals (NACE 244) 384 Medical Devices (NACE 331) 2836 Biotechnology (sub set of NACE 244) Together with partner or ISV-provided vertical solutions, Microsoft Axapta for Life Sciences helps Life Sciences companies in the midmarket and CAS segments manage their businesses while simplifying FDA validation Company Size 100+ Employees
Value Proposition
Provides Enterprise Group functionality designed to be implemented in accordance with the FDA’s current Good Manufacturing Practices GMP’s
- Title 21 of Code of Federal Regulations Part 11
- Need for increased system control
The solution is provided with comprehensive documentation to simplify the validation process
Reduces time and effort to validate a customized Microsoft Axapta for Life Sciences solution at the customer site
Provide documentation to pass FDA validation at a fraction of the cost of developing their own documentation
A Customer Solution Overview Implementation & Modifications Partner Vertical module (GMP) Microsoft Axapta for Life Sciences Microsoft Axapta Provider: Partner Microsoft Business Solutions Deliverables: Partner
Business Model Certification Partner will provide: Qualification Partner Qualification
Microsoft Business Solutions will provide:
A Microsoft Axapta solution that has been modified for the requirements of the Life Sciences industry
Comprehensive documentation of the solution, to simplify validation
Sales toolbox
Marketing toolbox
License distribution
Product Support
Sustained Engineering
Microsoft Business Solutions Customer Certification Partner
Qualification of Microsoft Axapta 3.0 for Life Sciences
Certification of partners
Channel building
Consultancy services to partners
Distribution of a vertical solution to sales and implementation partners
Work with Microsoft Business Solutions to execute sales & marketing efforts
Contact customers on the request of partners. Never directly.
Microsoft Business Solutions Subsidiary Sales & Implementation Partner Certification
What will the Sales and Implementation Partner Provide? They will implement and customize Microsoft Axapta 3.0 for Life Sciences and perhaps a Life Sciences-specific vertical solution, to support the specific business processes of each customer. The partners are certified, so customers can have confidence that the partner has the skills and capabilities needed to provide a validated implementation
NNIT- first Certification partner
Contact: Phillip Rubino
[email_address] , +45 3079 9232
Potential partner services:
Implementation and customization of Microsoft Axapta 3.0 for Life Sciences
Implementation of Life Sciences-specific verticals
Validation of complete solution
Training of end-users
Consultancy services related to defining customers processes
Certification Requirements for the Sales and Implementation Partner:
Quality Management System
Quality Assurance unit or roles are defined
Standard Operating Procedures for
Software development
Deployment
Maintenance
Customer support
Partner’s own IT installations in control
Employee Training Program
Awareness of computer validation requirements in the Life Sciences industry
NNIT Partner Program Sales & Marketing Program
Presales assistance
Implementation Validation assistance
Sales toolbox
Sales training in
How to sell to the Life Science Industry
How to sell Microsoft Axapta for Life Science
How to sell the vertical solution for the Life Science Industry
Certification package includes:
Introductory Course
Computer validation in the Life Sciences industry
Product training
Written guidelines and instructions on validation activities e.g.
Validation Planning
Specifications
Test and verification etc.
Generic templates for validation documentation e.g.
Validation Plan
Installation Qualification Protocol
Performance Qualification Protocol etc.
Certification Process
Introduction
Certification audit
Remedy issues
Training
Computer validation guidelines
Axapta validation templates
Final assessment
Issuance of Axapta for Life Sciences Certificate
Time line
Product Readiness
Product Release Date: Q1 CY05
Initial geographies on price list
US, European Union, Canada, Switzerland
Language versions
The core Microsoft Axapta functionality will be available in any of the languages supported by Microsoft Axapta 3.0
However, the additional functionality provided by Microsoft Axapta for Life Sciences (electronic signature) will be labeled in US English language only
Marketing & Support
Marketing:
November 1: Press release
January timeframe:
Launch paper (marketing white paper)
Story on Microsoft.com
Technical white paper
Life Science council briefing
Fact Sheet
Customer BDM & TDM presentation
Life Sciences Roadshow – January/February 2005
Case studies (6 months - 1 year after launch)
Support:
Support for Microsoft Axapta 3.0 for Life Sciences will be provided through Global Technical Support Centres – GTSC
Definitions Food and Drug Administration. It is the United States governmental agency responsible for the evaluation and approval of medical devices. FDA Validation Qualification 21 CFR Part 11 GMP Establishing documented evidence that provides a high degree of assurance that a specific process will consistently produce a product meeting its predetermined specifications and quality attributes. Ref.: FDA.
The process of demonstrating whether an entity is capable of fulfilling specified requirements. Ref.: ISO 8402.
Qualification of an IT application includes:
Assessment if the specifications are appropriate for the intended use
Verification that the functionalities actually are in accordance with specifications
Title 21 of Code of Federal Regulations Part 11. Regulation issued by FDA regarding use of electronic records and electronic signatures. Good Manufacturing Practice (regulation); GMP is a set of regulations requiring that quality, safety, and effectiveness be built into foods, drugs, medical devices, and biological products.
0 comments
Post a comment